Pediatric disease burden and vaccination recommendations: understanding local differences

Angela Gentile1, Zulfiqar Bhutta, Lulu Bravo

  • 1Ricardo Guiterrez Children's Hospital, Gallo Buenos Aires, Argentina. angelagentile@fibertel.com.ar

Insights

Vaccination coverage for diseases like diphtheria, tetanus, and pertussis varies globally. Combination vaccines (DTwP-HepB-Hib) offer a cost-effective way to improve coverage and reduce disease burden.

Area of Science:

  • Public Health
  • Vaccinology
  • Epidemiology

Background:

  • Diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, and measles cause significant global health issues.
  • These vaccine-preventable diseases contribute to substantial worldwide morbidity and mortality.

Purpose of the Study:

  • To review geographic variations in disease burden for D, T, P, HepB, and Hib.
  • To analyze vaccination coverage and recommendations across different World Health Organization (WHO) regions.
  • To illustrate these differences using country-specific examples.

Main Methods:

  • Comparative analysis of disease incidence and vaccination coverage data.
  • Review of national vaccination schedules and recommendations.
  • Geographic comparison across African, Americas, Mediterranean, South-East Asian, and Western Pacific WHO regions.

Main Results:

  • Significant disparities in disease incidence and vaccination coverage were observed between countries.
  • Low vaccination coverage for Hepatitis B and invasive Hib disease was noted in several WHO regions, particularly in Africa and South-East Asia.
  • Some countries' vaccination schedules lacked or recently introduced HepB and Hib vaccines; DTwP-HepB-Hib combination vaccines are increasingly adopted.

Conclusions:

  • Vaccination coverage and schedules differ significantly across countries, often influenced by available resources.
  • DTwP-HepB-Hib combination vaccines are a cost-effective strategy to enhance vaccination coverage and compliance.
  • These combination vaccines hold potential for substantially reducing the burden of these serious diseases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.